Invacare Holdings (IVC) Inventory Turnover Ratio, from first quarter 2023 to first quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Invacare Holdings Corporation  (IVC)
 

Invacare Holdings Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Invacare Holdings Corporation inventory turnover ratio, the Invacare Holdings Corporation's ability to sell and replace its inventory in the first quarter 2023, sequentially increased to 3.4 in the first quarter 2023, yet the ratio remained below the average, as IVC's market remain challenging.Average inventory processing period, for the Invacare Holdings in Mar 31 2023 quarter, has decreased to 107 days, compare to 109 days, in the Dec 31 2022 quarter.

Within Healthcare sector 127 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2023, to 801, from total ranking in the fourth quarter 2022 at 884.

IVC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Invacare Holdings Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IVC Inventory Turnover Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Inventory Growth -29.67 % -21.98 % -20.25 % -3.97 % 11.3 %
Y / Y Cost of Sales Growth -20.63 % -18.32 % -94.72 % -14.55 % 8.26 %
Inventory Turnover Ratio (TTM) 3.4 3.36 3.38 4.27 4.39
IVC's Total Ranking # 801 # 884 # 928 # 1022 # 1022
Average inventory processing period 107 109 108 85 83
Seq. Inventory Growth -7.93 % -6.73 % -13.05 % -5.8 % 2.13 %
Seq. Cost of Sales Growth -8.56 % 1437.59 % -93.87 % -7.98 % -5.89 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 45
Healthcare Sector # 128
Overall Market # 801

Inventory Turnover Ratio Statistics
High Average Low
5.74 4.94 3.36
(Mar 31 2015)   (Dec 31 2022)



IVC Company Profile >> Back to IVC Efficiency Comparisons >> Compare IVC Inventory Turnover Ratio to its Competitors

Financial Statements
Invacare Holdings's Inventories $ 104 Millions Visit IVC's Balance sheet
Invacare Holdings's Cost of Revenues TTM $ 404 Millions Visit IVC's Income Statement
What are IVC's Sales? Visit IVC's Sales by Segment

Other Inventory Turnover Ratios
Invacare Holdings's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IVC's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IVC's Competitors
Inventory Turnover Ratio for IVC's Suppliers
Inventory Turnover Ratio for IVC's Customers

You may also want to know
IVC's Sales Growth Rates IVC's Pe Price to earnings ratio IVC's Receivables Turnover Ratio IVC's Stock Quote
IVC's Net Income Growth Rates IVC's Ps Price to Sales ratio IVC's Sales per Employee IVC's Asset Turnover Ratio
IVC's Net Margin IVC's Pb Price to Book ratio IVC's Financial Strength Ratios IVC's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2023 Inventories at quarter ending Mar 31 2023
Infusystem Holdings Inc  10.17 $ 51.367  Millions$ 5  Millions
Cryo cell International Inc   9.88 $ 8.757  Millions$ 1  Millions
Prophase Labs Inc   9.47 $ 41.922  Millions$ 4  Millions
Castle Biosciences Inc   9.25 $ 36.247  Millions$ 4  Millions
Lftd Partners Inc   9.23 $ 31.814  Millions$ 3  Millions
Dermtech Inc   9.19 $ 14.138  Millions$ 2  Millions
Semler Scientific inc   9.03 $ 4.551  Millions$ 1  Millions
Novavax inc   9.00 $ 921.521  Millions$ 102  Millions
Irhythm Holdings Inc   8.90 $ 134.425  Millions$ 15  Millions
Agile Therapeutics Inc  8.65 $ 16.612  Millions$ 2  Millions
Genedx Holdings Corp   8.63 $ 241.031  Millions$ 28  Millions
Charles River Laboratories International inc   8.57 $ 2,221.931  Millions$ 259  Millions
Camp4 Therapeutics Corporation  8.46 $ 185.938  Millions$ 22  Millions
Bionexus Gene Lab Corp   8.01 $ 8.983  Millions$ 1  Millions
Cardiff Lexington Corporation  7.97 $ 4.305  Millions$ 1  Millions
Kaya Holdings Inc   7.79 $ 0.178  Millions$ 0  Millions
Kewaunee Scientific Corporation  7.72 $ 183.906  Millions$ 24  Millions
Dmk Pharmaceuticals Corporation  7.58 $ 6.512  Millions$ 1  Millions
Zai Lab Limited  7.41 $ 79.712  Millions$ 11  Millions
Societal Cdmo Inc   7.09 $ 70.241  Millions$ 10  Millions
National Vision Holdings Inc   7.03 $ 875.677  Millions$ 125  Millions
Nutriband Inc   6.90 $ 1.306  Millions$ 0  Millions
Opko Health Inc   6.84 $ 520.405  Millions$ 76  Millions
Novan Inc   6.70 $ 8.458  Millions$ 1  Millions
Collegium Pharmaceutical Inc   6.45 $ 357.740  Millions$ 55  Millions
Inogen Inc   6.18 $ 219.758  Millions$ 36  Millions
Hims and Hers Health Inc   6.12 $ 128.981  Millions$ 21  Millions
Fonar Corporation  6.09 $ 15.402  Millions$ 3  Millions
Patterson Companies Inc   5.85 $ 5,098.526  Millions$ 872  Millions
Nabriva Therapeutics Plc  5.73 $ 29.658  Millions$ 5  Millions

Date modified: 2026-09-08T15:10:58+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.